HSCT No Better Than Chemo in Philadelphia-Negative ALL

This article originally appeared here.
Share this content:
HSCT No Better Than Chemo in Philadelphia-Negative ALL
HSCT No Better Than Chemo in Philadelphia-Negative ALL

THURSDAY, June 2, 2016 (HealthDay News) -- For patients ≥40 years of age with Philadelphia (Ph)-negative acute lymphoblastic leukemia (ALL), hematopoietic stem-cell transplantation (HSCT) in first remission is associated with lower cumulative incidence of relapse (CIR), but worse non-relapse mortality (NRM), compared with chemotherapy alone, according to a study published online May 6 in the American Journal of Hematology.

Ofir Wolach, M.D., from the Dana-Farber Cancer Institute in Boston, and colleagues examined whether HSCT in first remission confers a survival benefit versus chemotherapy alone in patients ≥40 years of age with Ph-negative ALL. The outcome of patients treated with HSCT or chemotherapy alone in first remission (40 patients in each cohort) was compared.

The researchers observed no significant difference in three-year overall survival (OS) and disease-free survival (DFS) between the chemotherapy alone and HSCT groups (OS, 46 versus 40 percent; P = 0.35; DFS, 31 versus 40 percent; P = 0.98). The three-year CIR was 61 and 28 percent for the chemotherapy-only and HSCT groups, respectively (P = 0.011), while three-year NRM was 9 and 32 percent, respectively (P = 0.014).

"Allogeneic transplantation for patients ≥40 years with Ph-negative ALL in first remission is associated with a lower CIR but this benefit is offset by considerable NRM as compared with chemotherapy-only approach," the authors write. "HSCT may be beneficial in patients with high-risk disease features."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

U.S. Teens Not Getting Enough Moderate/Vigorous Exercise

U.S. Teens Not Getting Enough Moderate/Vigorous Exercise

And bad habits continue after high school for most

Cancer Patients Have Unrealistic Hopes Entering Clinical Trials

Cancer Patients Have Unrealistic Hopes Entering Clinical Trials

Study finding is a red flag, researcher says

Increased HIV Testing Among Men Who Have Sex With Men

Increased HIV Testing Among Men Who Have Sex ...

Data from 21 jurisdictions show higher percentages with negative HIV test 12 months before diagnosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »